Shaanxi University of Chinese medicine, Xianyang, 712046, PR China; Shaanxi Institute of International Trade & Commerce, Xianyang, 712046, PR China.
Xi'an Jiaotong University, Xi'an, 710061, PR China.
Biomed Pharmacother. 2019 Dec;120:109408. doi: 10.1016/j.biopha.2019.109408. Epub 2019 Sep 18.
Serotonin, which also named as 5-hydroxytryptamine (5-HT), is a neurotransmitter, which plays significant roles in a wide range of physiological and pathological processes. Depression is a complex disease that involves numerous factors, increasing evidences have showed that the level of 5-HT was lower in depressed patients and the administration of some selective serotonin re-uptake inhibitors exhibited antidepressant effects. The 5-HT1A receptor is a key protein in the brain serotonin system, modulating the release of 5-HT and other neurotransmitters. Behavioral and molecular biological studies have demonstrated that the differences of 5-HT1A receptor regulation was connected with depression and the responses to antidepressants. In this review, the authors will introduce the structure and function of 5-HT1A receptor and summarize some antidepressants targeting 5-HT1A receptor, including 5-HT1A receptor agonists and antagonists in a clinic, active ingredients of traditional Chinese medicine. And we found the major of drugs by targeting 5-HT1A receptor on the market or in clinical trials mostly have the similar functional groups, such as piperazine, piperidine, and pyrimidine. There are also some literatures found that these functional groups may be the site produce activity. So, we hope that it may provide basis and references for the research of the clinical drugs for depression.
血清素,也被称为 5-羟色胺(5-HT),是一种神经递质,在广泛的生理和病理过程中发挥重要作用。抑郁症是一种复杂的疾病,涉及许多因素,越来越多的证据表明,抑郁症患者的 5-HT 水平较低,一些选择性 5-羟色胺再摄取抑制剂的给药表现出抗抑郁作用。5-HT1A 受体是大脑血清素系统中的关键蛋白,调节 5-HT 和其他神经递质的释放。行为和分子生物学研究表明,5-HT1A 受体调节的差异与抑郁症和对抗抑郁药的反应有关。在这篇综述中,作者将介绍 5-HT1A 受体的结构和功能,并总结一些针对 5-HT1A 受体的抗抑郁药,包括临床应用的 5-HT1A 受体激动剂和拮抗剂,以及一些中药的活性成分。我们发现,市场上或临床试验中大多数针对 5-HT1A 受体的药物主要具有相似的功能基团,如哌嗪、哌啶和嘧啶。也有一些文献发现,这些功能基团可能是产生活性的部位。因此,我们希望这能为抑郁症的临床药物研究提供依据和参考。